创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: What are the advantages of the GVHD experiment platform?

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-19 13:34
  • Views:

(Summary description)In the field of modern medicine, with the progress of science and technology and the depth of research, we have gradually recognized the complexity and diversity of many diseases. Among them, Graft-versus-Host Disease (GVHD), as a common immune disease, has been the focus of attention of the medical community. In order to study the pathogenesis of GVHD more deeply and explore effective treatment methods, the GVHD experimental platform of InnoModels Biotechnology has emerged as an important tool in the field of scientific research

InnoModels Biotechnology: What are the advantages of the GVHD experiment platform?

(Summary description)In the field of modern medicine, with the progress of science and technology and the depth of research, we have gradually recognized the complexity and diversity of many diseases. Among them, Graft-versus-Host Disease (GVHD), as a common immune disease, has been the focus of attention of the medical community. In order to study the pathogenesis of GVHD more deeply and explore effective treatment methods, the GVHD experimental platform of InnoModels Biotechnology has emerged as an important tool in the field of scientific research

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-19 13:34
  • Views:
Information

In the field of modern medicine, with the progress of science and technology and the depth of research, we have gradually recognized the complexity and diversity of many diseases. Among them, Graft-versus-Host Disease (GVHD), as a common immune disease, has been the focus of attention of the medical community. In order to study the pathogenesis of GVHD more deeply and explore effective treatment methods, the GVHD experimental platform of InnoModels Biotechnology has emerged as an important tool in the field of scientific research.
1. Highly simulate the human environment
The GVHD experimental platform of InnoModels Biotechnology can highly simulate the internal environment of the human body, providing researchers with near-real experimental conditions. By simulating the immune system, tissue structure and physiological responses of different individuals, the platform can more accurately reflect the occurrence and development of GVHD in the human body, providing strong support for disease research.
2. Diversified experimental methods
The platform integrates a variety of experimental tools, such as cell culture, molecular biology, immunological analysis, etc., providing researchers with comprehensive and detailed research tools. Researchers can choose appropriate experimental tools according to different experimental needs, so as to better analyze the pathogenesis of GVHD.
3. Accurate drug screening and evaluation
InnoModels Bio's GVHD experimental platform can not only simulate the disease process, but also accurately screen and evaluate potential therapeutic drugs. Through this platform, researchers can quickly screen drugs with therapeutic potential and evaluate their efficacy and safety, providing strong support for clinical drug development.

 


4. Efficient data integration and analysis
In modern biomedical research, data integration and analysis has become an essential skill. Equipped with an advanced data processing system, the GVHD experimental platform can efficiently integrate and analyze the experimental data, helping researchers to find out the key information in the experiments more quickly and promote the scientific research process.
5. Promote the transformation of scientific research results
InnoModels' GVHD experimental platform not only provides researchers with powerful research tools, but also actively promotes the transformation of research results. Through cooperation with medical institutions and pharmaceutical companies, the platform applies research results to clinical practice, providing patients with more effective treatments and promoting the progress of the medical field.
In summary, the GVHD experimental platform of InnoModels Biotechnology has become a powerful tool for researching the pathogenesis and therapeutic methods of GVHD with its advantages of highly simulating the human environment, diversified experimental methods, accurate drug screening and evaluation, efficient data integration and analysis, and promotion of the transformation of scientific research results. In the future, with the advancement of science and technology and in-depth research, the platform is expected to bring more breakthroughs and discoveries in the field of medicine and make greater contributions to human health.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司